{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:39:21Z","timestamp":1774658361980,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.bcp.2003.10.035","type":"journal-article","created":{"date-parts":[[2004,1,15]],"date-time":"2004-01-15T05:19:27Z","timestamp":1074143967000},"page":"1131-1138","source":"Crossref","is-referenced-by-count":23,"title":["The combi-targeting concept: intracellular fragmentation of the binary epidermal growth factor (EGFR)\/DNA targeting \u201ccombi-triazene\u201d SMA41"],"prefix":"10.1016","volume":"67","author":[{"given":"Stephanie L","family":"Matheson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Brahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand J","family":"Jean-Claude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2003.10.035_BIB1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1006217413089","article-title":"Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest by deprivation of epidermal growth factor","volume":"55","author":"Chou","year":"1999","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.bcp.2003.10.035_BIB2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/bjc.1998.142","article-title":"Epidermal growth factor receptor activation in androgen-independent but not androgen-dependent growth of human prostate carcinoma cells","volume":"77","author":"Sherwood","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2003.10.035_BIB3","first-page":"6500","article-title":"Activated extracellular signal-related kinases: association with epidermal growth factor receptor\/transforming growth factor-\u03b1 expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments","volume":"61","author":"Albanell","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2003.10.035_BIB4","first-page":"54s","article-title":"New therapeutic agents targeting the epidermal growth factor receptor","volume":"18","author":"Baselga","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2003.10.035_BIB5","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1200\/JCO.2002.03.100","article-title":"Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types","volume":"20","author":"Baselga","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2003.10.035_BIB6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1126\/science.8066447","article-title":"A specific inhibitor of the epidermal growth factor receptor tyrosine kinase","volume":"265","author":"Fry","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bcp.2003.10.035_BIB7","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm00018a008","volume":"38","author":"Rewcastle","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2003.10.035_BIB8","first-page":"832","article-title":"Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy","volume":"296","author":"Matheson","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2003.10.035_BIB9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00280-002-0525-4","article-title":"Differential responses of EGFR\/AGT-expressing cells to the \u201ccombi-triazene\u201d SMA41","volume":"51","author":"Matheson","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.035_BIB10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/jpet.102.039099","article-title":"Inhibition of epidermal growth factor receptor-mediated signaling by \u201ccombi-triazene\u201d BJ2000, a new probe for combi-targeting postulates","volume":"303","author":"Brahimi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2003.10.035_BIB11","first-page":"37","article-title":"Triazene metabolism. V. Chemical and biological properties of N,B-bis-[1-aryl-3-methyltriazen-3-yl-methyl]-methylamines: potential prodrugs for the cytotoxic monomethyltriazenes","volume":"1","author":"Manning","year":"1985","journal-title":"Anticancer Drug Des."},{"key":"10.1016\/j.bcp.2003.10.035_BIB12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0305-7372(97)90019-0","article-title":"Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials","volume":"23","author":"Newlands","year":"1997","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.bcp.2003.10.035_BIB13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jlcr.713","article-title":"Synthesis of a 1-[4-(m-tolyl)amino-6-quinazolinyl-3-[14C]-methyl] triazene: a radiolabeled probe for the combi-targeting concept","volume":"46","author":"Matheson","year":"2003","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"10.1016\/j.bcp.2003.10.035_BIB14","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1016\/0006-2952(87)90636-8","article-title":"Antitumour imiazotetrazines-XVI macromolecular alkylation by 3-substituted imidazotetrazinones","volume":"36","author":"Bull","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl. A","key":"10.1016\/j.bcp.2003.10.035_BIB15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/ejpn.2000.0428","article-title":"Lysosomal membrane proteins","volume":"5","author":"Winchester","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.bcp.2003.10.035_BIB16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0959-8049(05)80221-7","article-title":"From triazines and triazenes to temozolomide","volume":"29","author":"Stevens","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2003.10.035_BIB17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0006-2952(87)90351-0","article-title":"Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones","volume":"36","author":"Tisdale","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.10.035_BIB18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1383-5742(00)00016-8","article-title":"Unmasking a killer: DNA O6-methylguanine and the cytotoxicity of methylating agents","volume":"462","author":"Bignami","year":"2000","journal-title":"Mut. Res."},{"key":"10.1016\/j.bcp.2003.10.035_BIB19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<744::AID-IJC19>3.0.CO;2-5","article-title":"Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance","volume":"80","author":"Lage","year":"1999","journal-title":"Int. J. Cancer"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295203008918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295203008918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T08:16:20Z","timestamp":1549613780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295203008918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0006295203008918"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2003.10.035","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}